HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Vernon Bernardino reaffirmed a Buy rating on Edesa Biotech (NASDAQ:EDSA) and maintained a $10 price target on the company's stock.
November 22, 2023 | 11:34 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Vernon Bernardino reiterated a Buy rating on Edesa Biotech and maintained a $10 price target.
The reiteration of a Buy rating and maintenance of a $10 price target by a reputable analyst could lead to increased investor confidence in Edesa Biotech, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100